HUP0104760A2 - Eljárás és készítmény a bél épségének megtartására és helyreállítására - Google Patents

Eljárás és készítmény a bél épségének megtartására és helyreállítására

Info

Publication number
HUP0104760A2
HUP0104760A2 HU0104760A HUP0104760A HUP0104760A2 HU P0104760 A2 HUP0104760 A2 HU P0104760A2 HU 0104760 A HU0104760 A HU 0104760A HU P0104760 A HUP0104760 A HU P0104760A HU P0104760 A2 HUP0104760 A2 HU P0104760A2
Authority
HU
Hungary
Prior art keywords
fatty acid
polyunsaturated fatty
amount
restitution
maintenance
Prior art date
Application number
HU0104760A
Other languages
English (en)
Inventor
Michael Scott Caplan
Susan Marie Kaup
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of HUP0104760A2 publication Critical patent/HUP0104760A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A tal lm ny t rgya elj r s a bél épségének megtart s ra és helyre llíts nak elősegítésére egy ilyen kezelésre szoruló egyénen. A tal lm nyszerinti elj r s abban ll, hogy ennek az egyénnek olyan készítménytadagolnak, amely legal bb egy <n-6< t"bbsz"r"sen telítetlen zsírsav éslegal bb egy <n-3< t"bbsz"r"sen telítetlen zsírsav kombin ciój nak hatsos mennyiségét tartalmazza, ahol az <n-6< zsírsavban a telítetlenk"tések a 6-os és az utolsó szénatom k"z"tt, míg az <n-3< zsírsavban a3-as és az utolsó szénatom k"z"tt vannak. A készítmény az n-6t"bbsz"r"sen telítetlen zsírsavat 4-50mg/100 ml mennyiségben, míg azn-3 t"bbsz"r"sen telítetlen zsírsavat 4-50 mg/ 100 ml mennyiségbentartalmazza. A készítmény az n-6 t"bbsz"r"sen telítetlen zsírsavat azn-3 t"bbsz"r"sen telítetlen zsírsavhoz viszonyítva (1:1)-(2,5:1) arnyban tartalmazza. Ó
HU0104760A 1998-12-15 1999-12-13 Eljárás és készítmény a bél épségének megtartására és helyreállítására HUP0104760A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11237498P 1998-12-15 1998-12-15
PCT/US1999/029478 WO2000035443A1 (en) 1998-12-15 1999-12-13 Method and composition for the maintenance and restitution of gut integrity

Publications (1)

Publication Number Publication Date
HUP0104760A2 true HUP0104760A2 (hu) 2002-04-29

Family

ID=22343574

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104760A HUP0104760A2 (hu) 1998-12-15 1999-12-13 Eljárás és készítmény a bél épségének megtartására és helyreállítására

Country Status (14)

Country Link
EP (1) EP1140063A1 (hu)
JP (1) JP2002532420A (hu)
KR (1) KR20020002361A (hu)
CN (1) CN1330542A (hu)
AR (1) AR021669A1 (hu)
AU (1) AU3119600A (hu)
BR (1) BR9916156A (hu)
CA (1) CA2351469A1 (hu)
EA (1) EA200100662A1 (hu)
HU (1) HUP0104760A2 (hu)
IL (1) IL143322A0 (hu)
NO (1) NO20012947D0 (hu)
PL (1) PL348810A1 (hu)
WO (1) WO2000035443A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1863463B (zh) 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
JP2007063219A (ja) * 2005-09-01 2007-03-15 Juntendo 新生児壊死性腸炎疾患予防剤
ES2674430T3 (es) 2010-12-29 2018-06-29 Abbott Laboratories Producto nutricional para mejorar la tolerancia, digestión y absorción de nutrientes liposolubles en un lactante, niño pequeño o niño
MX2017003660A (es) * 2014-09-30 2017-06-26 Nestec Sa Composicion nutricional que se usa para promover la maduracion y/o reparacion del intestino y/o del higado.
WO2023245470A1 (zh) * 2022-06-22 2023-12-28 南方医科大学珠江医院 Mdp类似物在制备用于治疗炎症性肠病的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
DE3603000A1 (de) * 1986-01-31 1987-08-06 Milupa Ag Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
DE4417851C1 (de) * 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use

Also Published As

Publication number Publication date
WO2000035443A9 (en) 2000-12-07
IL143322A0 (en) 2002-04-21
AU3119600A (en) 2000-07-03
JP2002532420A (ja) 2002-10-02
BR9916156A (pt) 2001-09-04
CN1330542A (zh) 2002-01-09
NO20012947L (no) 2001-06-14
KR20020002361A (ko) 2002-01-09
PL348810A1 (en) 2002-06-17
NO20012947D0 (no) 2001-06-14
EP1140063A1 (en) 2001-10-10
AR021669A1 (es) 2002-07-31
WO2000035443A1 (en) 2000-06-22
CA2351469A1 (en) 2000-06-22
EA200100662A1 (ru) 2001-12-24

Similar Documents

Publication Publication Date Title
Siegel et al. The differential effects of prenatal and postnatal audiogenic stress on fluctuating dental asymmetry
WO2001070664A3 (en) Lipoxin analogs and methods for the treatment of periodontal disease
HUP9900864A2 (hu) Eljárás esszenciális aminosavak felgyülemlésének növelésére magokban
MA24425A1 (fr) Preventio de la perte et restauration de la masse osseuse par certains agonistes des prostaglandines.
HUP0104760A2 (hu) Eljárás és készítmény a bél épségének megtartására és helyreállítására
AR002442A1 (es) Formulaciones orales de ibuprofeno s (+)
TR199902802T2 (xx) Kardiyovask�ler hastal�klar ve enflamatuar hastal�klar�n tedavisi i�in probukol monoesterleri.
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
GB2318977B (en) Compositions
ATE197389T1 (de) Zahnimplantat und verfahren zu seiner herstellung
PT859608E (pt) Tratamento de niddm com agonistas de rxr
IS2983B (is) Fastar lyfjasamsetningar sem innihalda 4-amínó-3-setnar-smjörsýruafleiður valdar úr gabapentíni og/eða pregabalíni og aðferð við að framleiða þær
Li et al. The effects of fixed orthodontic appliances on saliva flow rate and saliva electrolyte concentrations
DE59000791D1 (de) Einzelzahnimplantat.
CA2130575A1 (en) Petroleum Wax-Free Chewing Gums Having Improved Flavor Release
PT1216041E (pt) Dieta com elevado teor de lipidos
HUP0003899A2 (hu) Kétkomponensű fogápoló készítmény a fog fluoridtartalmának növelésére
DK0560425T3 (da) Forbedrede chokoladesammensætninger baseret på hardstock-fedtadditiver
BR9811888A (pt) Composições aromatizantes melhoradas contendo n-etil-p-mentano-3-carboxamida e método para produzir e usar as mesmas
PL325472A1 (en) Method of marking objects and objects and marked thereby
PT1051159E (pt) Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
ATE445332T1 (de) Glutaminhaltige zusammensetzung gegen diarrhö
WO2002092779A3 (en) Method for enriching tissues in long chain polyunsaturated fatty acids
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
EP0843109A3 (en) Drum brake device